首页|原发性前列腺印戒细胞癌的诊疗进展

原发性前列腺印戒细胞癌的诊疗进展

Progress in diagnosis and treatment of primary prostatic signet ring cell carcinoma

扫码查看
原发性前列腺印戒细胞癌(PPSRCC)是男性泌尿生殖系统中极为罕见的恶性肿瘤之一,诊断主要依靠病理组织学和免疫组化染色检查.PPSRCC的侵袭性强、治疗反应较低、预后较差.本文概述PPSRCC发生机制、临床表现、病理学特点、诊断、治疗和预后方面的研究进展.
Primary prostate signet ring cell carcinoma(PPSRCC)is one of the extremely rare malignant tumors in the male urogenital system,and its diagnosis mainly relies on pathological and immunohistochemical examination.Compared with typical prostate cancer,PPSRCC is characterized by more aggressive with less treatment response and poor prognosis.Current researches on the pathogenesis,clinical manifestations,pathological characteristics,diagnosis,treatment and prognosis of PPSRCC were reviewed.

Prostatic neoplasmsCarcinomaSignet ring cell

王浩、谢大炜、王思琦、李馨、杨朴深、何威峰、王建文

展开 >

首都医科大学附属北京朝阳医院泌尿外科,北京 100020

前列腺肿瘤 印戒细胞

首都卫生发展科研专项项目

首发2020-2-2033

2024

中华泌尿外科杂志
中华医学会

中华泌尿外科杂志

CSTPCD北大核心
影响因子:1.628
ISSN:1000-6702
年,卷(期):2024.45(8)